These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Cutaneous Waldenstrom macroglobulinemia in transformation. Appenzeller P; Leith CP; Foucar K; Scott AA; Bigler CF; Thompson CT Am J Dermatopathol; 1999 Apr; 21(2):151-5. PubMed ID: 10218675 [TBL] [Abstract][Full Text] [Related]
26. [Osseous and osteoarticular manifestations associated with Waldenstrom's disease. Favorable prognosis for dysglobulinemia under the influence of chlorambucil]. Mémin Y; Vigne J; Bouchat R; Pattin S; Lechat S Ann Med Interne (Paris); 1969 Nov; 120(11):739-47. PubMed ID: 4983441 [No Abstract] [Full Text] [Related]
27. IgG-lambda secreting B-lymphoplasmacytic lymphoma with disseminated cutaneous infiltration: report of a rare case. Kyriakou E; Kolovou K; Kotsopoulou M; Mahera H; Spiliotopoulou I J BUON; 2009; 14(4):695-8. PubMed ID: 20148464 [TBL] [Abstract][Full Text] [Related]
28. [Leukeran in treatment of macroglobulinemia]. Bromberg-Sznek S; Szulkin E; Wolańska A Pol Tyg Lek; 1971 Aug; 26(32):1242-3. PubMed ID: 4999600 [No Abstract] [Full Text] [Related]
29. Cutaneous Infiltration due to Waldenström Macroglobulinemia. Oscoz-Jaime S; Agulló-Pérez AD; Llanos-Chavarri C; Yanguas-Bayona JI Actas Dermosifiliogr (Engl Ed); 2018; 109(1):75-78. PubMed ID: 28784233 [No Abstract] [Full Text] [Related]
31. [Hepatocellular carcinoma in an African after 10 years of treatment of Waldenstrom's disease with chlorambucil]. Renambot J; Aubry P; Menard M; Dano P; Brunetti G Nouv Presse Med; 1982 Jul 10-17; 11(32):2418. PubMed ID: 6287413 [No Abstract] [Full Text] [Related]